GET DAILY SIGNALSMarcus Corporation (MCS) Reports Record Q3 Revenue with 13.1% Growth
Key Takeaways
- The Marcus Corporation posted record consolidated revenue of $238 million for the third quarter of 2026, a 13.1% increase from the prior year and the highest quarterly revenue in its history.
- Operating income climbed 33% to $30.3 million, while adjusted EBITDA rose 21% to $49.1 million.
- Net earnings reached $18.8 million, or $0.60 per share, versus $13.2 million, or $0.42 per share, in the year-ago quarter after excluding a non-recurring insurance gain.
- The theatre division fueled the results, with revenue advancing about 21% to $145 million and comparable attendance up 16.8% on strong titles such as "Spider-Man: Brand New Day" and "The Odyssey."
- The hotels and resorts division recorded a modest 2% revenue increase, as softer group demand and storm-related costs weighed on performance despite solid leisure travel.
Earnings Context and Why It Matters
The third quarter of 2026 closed out Marcus Corporation’s seasonally strongest period, covering peak summer box office and leisure travel months. The Milwaukee-based firm runs two main businesses: Marcus Theatres, the fourth-largest U.S. theatre circuit, and Marcus Hotels & Resorts, which owns and manages hotel properties. Both segments achieved record third-quarter revenue, reflecting ongoing recovery in moviegoing and steady travel demand. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Investors follow these results because theatre profitability depends heavily on film slates, while hotels hinge on RevPAR trends, group bookings, and cost management. The quarter offers useful insight into consumer discretionary spending and the durability of the post-pandemic entertainment rebound.
Reported Results
Marcus Corporation reported consolidated revenue of $238 million for the third quarter of 2026, up 13.1% from the prior-year period and ahead of the Zacks Consensus Estimate of roughly $236.31 million. Operating income increased 33% to $30.3 million, and adjusted EBITDA grew 21% to $49.1 million. Net earnings totaled $18.8 million, or $0.60 per share, compared with $13.2 million, or $0.42 per share, a year earlier after stripping out a prior-year non-recurring insurance gain of about $0.10 per share. Earnings per share of $0.60 came in just below the Zacks consensus of $0.62, while revenue slightly topped expectations.
The theatre division led with revenue of approximately $145 million, up about 21%, as comparable attendance rose 16.8% and average admission prices increased 4.3%. The hotels and resorts division produced revenue before cost reimbursements of $82 million, up 2%, with comparable owned-hotel RevPAR advancing 7.4%. The company finished the quarter with roughly $60 million in cash, more than $219 million in total liquidity, and net leverage of 0.8 times.
Market Reaction and Investor Sentiment
The initial market reaction was mixed yet generally constructive. Record revenue and theatre momentum supported sentiment, while the modest earnings-per-share miss versus consensus and softer group demand in hotels limited enthusiasm. The theatre segment’s adjusted EBITDA jump of more than 46% underscored operating leverage from blockbuster attendance, a dynamic investors have rewarded in strong film quarters. At the same time, the hotel division’s essentially flat adjusted EBITDA—hit by storm damage at Grand Geneva Resort & Spa, adverse property tax assessments, and a shift toward lower-margin transient business—highlighted that the hospitality recovery remains uneven. Overall, the results reinforced the story of a resurgent theatrical business balanced against steadier hotel performance.
Forward Outlook and Key Factors to Monitor
Management highlighted a promising fourth-quarter film slate that includes "Avengers: Doomsday" and "Dune: Part Three," with advance ticket sales for "Avengers: Doomsday" described as very strong. A broader holiday lineup and a solid 2027 franchise schedule, including titles such as "Shrek 5," "Frozen 3," and "Star Wars: Starfighter," point to continued theatre attendance potential. Investors should track whether premium-format penetration and per-capita spending stay elevated, as these factors support theatre profitability beyond raw attendance numbers. In the hotels and resorts division, the pace of group business recovery, especially in Milwaukee, and the timing of insurance recoveries related to Grand Geneva storm damage remain key variables. Management reaffirmed fiscal 2026 capital expenditures guidance of $45 million to $50 million, with higher fourth-quarter project spending anticipated. A stronger balance sheet with $60 million in cash, more than $219 million in total liquidity, and low leverage provides room for reinvestment and the quarterly dividend. Cost control, film terms with distributors, and the mix between transient and group hotel demand will stay central to sustaining momentum going forward.
How Tickeron AI Tools Fit Into My Research
When analyzing names like MCS, I find Tickeron’s AI Screener helpful for quickly filtering stocks by technical patterns, fundamentals, and performance metrics. It lets me compare companies across sectors without spending hours on manual screens and often surfaces ideas I might otherwise overlook. The tool integrates well with my regular review of earnings and industry trends.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
MCS's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for MCS turned positive on October 13, 2026. Looking at past instances where MCS's MACD turned positive, the stock continued to rise in 25 of 36 cases over the following month. The odds of a continued upward trend are 69%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
MCS moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MCS crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 65%.
Following a +1.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where MCS advanced for three days, in 197 of 289 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
MCS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 27, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MCS as a result. In 47 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MCS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
The Aroon Indicator for MCS entered a downward trend on October 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. MCS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 40 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock slightly better than average.
The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.904) is normal, around the industry mean (12.534). P/E Ratio (37.627) is within average values for comparable stocks, (38.830). Projected Growth (PEG Ratio) (2.499) is also within normal values, averaging (2.376). Dividend Yield (0.013) settles around the average of (0.045) among similar stocks. P/S Ratio (1.082) is also within normal values, averaging (2.932).
The Tickeron SMR rating for this company is 83 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
an operator of hotels, resorts and movie theaters
Industry MoviesEntertainment
Advertisement